- Synthetic derivative of the amino acid lysine
- Commonly marketed in tablet form as Lysteda and in IV form as Cyklokapron in the U.S. and as Transamin,Transcam in Asia, and Espercil in South America
- Antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin
- Fibrin is the basic framework for the formation of a blood clot in hemostasis
- Has roughly 8 times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid
|
|
